Fortis Healthcare enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
53,678————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
424424140235141
273273253893858
2,8732,8732,475858926
56,399————
2,4482,4482,335623785
₹747.05————
13,04113,04111,6449,4149,026
22.0%22.0%21.3%9.1%10.3%
0.05×————
5.93×————
26.46×————
33.94×————
85.94×————
Reference items — trailing FY values
9,5069,1287,7836,8936,298
2,1312,0851,5881,2681,101
1,6621,6361,202925786
—1,6021,4241,100822
656656577158375
—589550125345
—946847942447
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FORTIS₹711.00

Fortis Healthcare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHMEDANTAAUROPHARMALUPINALKEMLAURUSLABSMANKINDMcap ₹53,678 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————53,677.7
- Cash, Equiv & ST Investments141.1235.3139.7424.3424.3
+ Minority Interest858.1893.2252.9273.0273.0
+ Total Debt925.7858.32,475.12,872.72,872.7
Enterprise Value————56,399.0
Net Debt (memo)784.6623.02,335.42,448.42,448.4
EV per Share————747.05
Total Capital9,026.19,414.411,644.513,041.213,041.2
Total Debt/Total Capital10.269.1221.2622.0322.03
Total Debt/EV————0.05
EV/Sales————5.93
EV/EBITDA————26.46
EV/EBIT————33.94
EV/Free Cash Flow————85.94
Reference Items — Trailing FY Values
Sales6,297.66,892.97,782.89,127.89,506.2
EBITDA1,101.31,267.61,587.92,085.02,131.4
EBIT785.6925.11,202.31,635.61,661.6
Operating Cash Flow822.21,100.11,423.91,601.8—
Free Cash Flow375.0157.6577.0656.3656.3
FCFF (free cash flow to the firm)345.4125.0549.6588.5—
Capital Expenditure447.2942.5846.9945.5—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.